This year, we announced our brand transition from Johnson & Johnson Medical Devices to Johnson & Johnson MedTech. It was a reflection of how our organisation is the world’s most broadly based MedTech company, and how we are committed to delivering breakthrough scientific innovation and reimagining health in an increasingly digital world.
Our UK & Ireland leaders have now sat down with the Clinical Services Journal to discuss their thoughts on how digital technologies and MedTech manufacturers have the potential to transform surgery by reducing variation, improving outcomes, and increasing efficiencies.
Read the full article online here: www.clinicalservicesjournal.com
About Johnson & Johnson MedTech:
At Johnson & Johnson MedTech, we unleash diverse healthcare expertise, purposeful technology, and a passion for people to transform the future of medical intervention and empower everyone to live their best life possible. For more than a century, we have driven breakthrough scientific innovation to address unmet needs and reimagine health. In surgery, orthopaedics, vision, and interventional solutions, we continue to help save lives and create a future where healthcare solutions are smarter, less invasive, and more personalized.